Johnson & Johnson and Pfizer are among leading pharmaceutical companies in the world seeking to further grow their revenue.
Both companies are able to grow its dividend consistently.
J&J has higher return on invested capital and better balance sheet than Pfizer.
Both companies have pipelines of products under development in the next few years.
READ FULL ARTICLE HERE
Einhorn, Barbarito, Frost & Botwinick, PC, is pleased to announce that Matthew S. Rheingold has been elevated from
Einhorn, Barbarito, Frost & Botwinick, PC, is pleased to announce that partners Thomas J. Snyder and Matheu D. Nunn
Mark H. Anania, a partner at McCarter & English, LLP, has been named President of the New Jersey Intellectual Property Law Association
Cohen Seglias Pallas Greenhall & Furman PC is pleased to announce that Anthony H. Chwastyk has joined the
For partnerships, content marketing or advertising inquiries, please contact Edwin through his LinkedIn Profile
Connect© Copyright 2024 citybuzz
